STERIS plc (STE)
Market Cap | 19.71B |
Revenue (ttm) | 5.41B |
Net Income (ttm) | 566.84M |
Shares Out | 98.81M |
EPS (ttm) | 5.70 |
PE Ratio | 35.00 |
Forward PE | 21.12 |
Dividend | $2.08 (1.04%) |
Ex-Dividend Date | Feb 22, 2024 |
Volume | 509,331 |
Open | 201.73 |
Previous Close | 200.81 |
Day's Range | 197.84 - 202.44 |
52-Week Range | 180.54 - 254.00 |
Beta | 0.79 |
Analysts | Buy |
Price Target | 242.67 (+21.63%) |
Earnings Date | May 8, 2024 |
About STE
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lig... [Read more]
Financial Performance
In 2022, STERIS's revenue was $4.96 billion, an increase of 8.13% compared to the previous year's $4.59 billion. Earnings were $107.03 million, a decrease of -56.12%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for STE stock is "Buy." The 12-month stock price forecast is $242.67, which is an increase of 21.63% from the latest price.
News
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP
AUSTIN, Texas , April 11, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement t...
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) --) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental...
Steris beats third-quarter estimates on strong medical procedure demand
Medical equipment maker Steris beat third-quarter profit estimates, helped by strength in its core healthcare business driven by demand for surgical instruments as more patients catch up on procedures...
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Reven...
STERIS Announces Dividend of $0.52 per share
DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share....
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter finan...
STERIS Announces Financial Results for Fiscal 2024 Second Quarter
DUBLIN, IRELAND, Nov. 07, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 second quarter ended September 30, 2023. Re...
STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023
DUBLIN, IRELAND, Oct. 24, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second quarter fin...
STERIS to Present at the Morgan Stanley Healthcare Conference
DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City ...
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instru...
Medical device maker Steris lifts 2024 results view, records quarterly beat
Medical equipment provider Steris on Tuesday raised its profit forecast for fiscal 2024 after strength in its core healthcare business boosted first-quarter results above Wall Street estimates.
STERIS Announces Financial Results for Fiscal 2024 First Quarter
DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue ...
STERIS Raises Dividend to $0.52 per share
DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share....
STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023
DUBLIN, IRELAND, July 19, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first quarter fina...
Steris paying $540 mln for BD surgical instrument unit
Becton, Dickinson and Co. (BD) BDX, +0.96% said Tuesday it agreed to sell its surgical instrumentation platform to Steris for STE, +0.04% for $540 million, or about 3.2 times the annual revenue of $17...
BD to Sell Surgical Instrumentation Platform to STERIS
Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J. , June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a le...
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
DUBLIN, IRELAND , June 20, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the surgical instr...
STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year
DUBLIN, IRELAND , May 10, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 fourth quarter and full year ended March 31...
STERIS Appoints Esther M. Alegria, Ph.D.
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Esther M. Alegria, Ph.D. has been elected to the Board of Directors, effective...
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that STERIS's Board of Directors has authorized a new share buyback program for th...
STERIS to Host a Conference Call for Fiscal 2023 Fourth Quarter and Full Year Financial Results on May 11, 2023
DUBLIN, IRELAND, April 24, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 fourth quarter and...
STERIS Announces Financial Results for Fiscal 2023 Third Quarter
DUBLIN, IRELAND, Feb. 08, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Reve...
STERIS Declares $0.47 per share Dividend
DUBLIN, IRELAND, Feb. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share....
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter finan...
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
DUBLIN, IRELAND, Nov. 09, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Re...